Literature DB >> 30268489

Fibrin glue obliteration is safe, effective and minimally invasive as first line treatment for pilonidal sinus disease in children.

Ejo Hardy1, Pjj Herrod2, T Sian2, H Boyd-Carson2, Jem Blackwell2, J N Lund2, J W Quarmby3.   

Abstract

BACKGROUND /
PURPOSE: Sacrococcygeal pilonidal sinus disease (PSD) has an incidence of 1.2-2.5/1000 in children. Onset is around puberty. Symptoms of recurrent abscess and chronic suppuration may interfere with education and social integration. Treatments should cause minimal disruption while having good cure and recurrence rates. Curettage and Fibrin glue obliteration (FGO) show promising results in adults. We present our experience of its use in children.
METHODS: Review of all pediatric patients receiving FGO of pilonidal sinus performed by a single surgeon from September 2014 to February 2018.
RESULTS: Eighteen patients were identified. Median age was 16 (range 15-17), 55.6% were male. All procedures were completed as day cases. Median operative duration was 14 .1 (6-29) min. Twelve patients required only 1 procedure, 4 required 2 procedures, 1 required 5 procedures and 1 elected for formal excision after 2 FGO treatments. Median return to normal activities was 3 days, with 1 day school absence. Two patients developed minor surgical site infections. Median follow-up was 52 weeks (17-102), during which time there was 1 recurrence (5.6%).
CONCLUSION: This study demonstrates FGO is a safe, effective procedure for pediatric PNS, with results comparable to off-midline flap techniques and without the need for extensive tissue excision and the associated morbidity. LEVEL OF EVIDENCE: IV.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Fibrin; Glue; Outcomes; Pediatric; Pilonidal

Mesh:

Substances:

Year:  2018        PMID: 30268489     DOI: 10.1016/j.jpedsurg.2018.07.024

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Fibrin glue is a quick and effective treatment for primary and recurrent pilonidal sinus disease.

Authors:  T S Sian; P J J Herrod; J E M Blackwell; E J O Hardy; J N Lund
Journal:  Tech Coloproctol       Date:  2018-11-09       Impact factor: 3.781

2.  Initial experience with minimally invasive treatment of pilonidal sinus in children.

Authors:  Vojtech Dotlacil; Michal Rygl; Barbora Frybova
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-11       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.